The market already knew the deal was coming. IPG had disclosed the put-option arrangement and the €300 million purchase price on July 16, 2026; this filing mainly converts that expected transaction into a signed share purchase agreement after the French works-council process. The direction is confirmation, not a fresh strategic surprise. 〔0〕
| Item | Filing detail |
|---|---|
| Purchase price | €300 million, cash-free and debt-free (SPA description) |
| Maximum earn-out | Up to €50 million tied to 2026 and 2027 performance metrics (SPA description) |
| Funding | Cash on hand (SPA description) |
| Expected closing | Fourth quarter of 2026 (SPA description) |
The economics are unchanged rather than improved. The definitive agreement preserves the previously disclosed €300 million cash consideration and adds no new valuation or financing upside; the earn-out remains contingent, so the maximum €350 million headline price should not be treated as committed consideration. 〔1〕
The remaining development is execution risk, not deal discovery. Closing still depends on French foreign-investment authorization and an AMF waiver, with completion targeted for the fourth quarter of 2026. That leaves timing and regulatory clearance as the material next checkpoints, but the filing does not change the market's basic understanding of the transaction. 〔2〕
Net read: in line with the standing expectation. This is a formalization of an already announced acquisition on already disclosed terms, so the appropriate scorecard is the factual event—$300M acquisition—not a beat or miss. The filing removes one process milestone but does not yet deliver closing, operating results, or evidence that the earn-out will be paid.
Read the original 8-K on SEC EDGAR ↗